<--- Back to Details
First PageDocument Content
Management / Ethics / Immunosuppressants / Natalizumab / Biogen Idec / Risk / Health literacy / Patient safety / Medicine / Multiple sclerosis
Date: 2014-04-03 06:18:28
Management
Ethics
Immunosuppressants
Natalizumab
Biogen Idec
Risk
Health literacy
Patient safety
Medicine
Multiple sclerosis

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

Download Document from Web Archive

File Size: 58,01 KB